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Abstract: The population dynamics theory of B cells in a typical germinal center could 
play an important role in revealing how affinity maturation is achieved. However, the 
existing models encountered some conflicts with experiments. To resolve these conflicts, 
we present a coarse-grained model to calculate the B cell population development in 
affinity maturation, which allows a comprehensive analysis of its parameter space to look 
for optimal values of mutation rate, selection strength, and initial antibody-antigen 
binding level that maximize the affinity improvement. With these optimized parameters, 
the model is compatible with the experimental observations such as the ~100-fold affinity 
improvements, the number of mutations, the hypermutation rate, and the “all or none” 
phenomenon. Moreover, we study the reasons behind the optimal parameters. The 
optimal mutation rate, in agreement with the hypermutation rate in vivo, results from a 
tradeoff between accumulating enough beneficial mutations and avoiding too many 
deleterious or lethal mutations. The optimal selection strength evolves as a balance 
between the need for affinity improvement and the requirement to pass the population 
bottleneck. These findings point to the conclusion that germinal centers have been 
optimized by evolution to generate strong affinity antibodies effectively and rapidly. In 
addition, we study the enhancement of affinity improvement due to B cell migration 
between germinal centers. These results could enhance our understandings to the 
functions of germinal centers. 
 
Author Summary: The antibodies in our immune system could efficiently improve their 
abilities in recognizing new antigens. This is done with the help of proliferation, mutation 
and selection of B cells which carry antibodies; but we have difficulties in developing a 
quantitative description of this adaptation process which is consistent with the various 
aspects of experimental observations. Based on the knowledge from experiments, here 
we present a theoretical model to calculate the numbers of B cells with different antigen 
recognizing abilities all the time, and look for the best possible design that improves the 
antigen recognizing ability most efficiently. We find that the best possible design is 
consistent with the experimental observations, pointing to the conclusion that the immune 
system has been optimized in evolution. We then study the trade-offs leading to the 
optimization of the design. The results will not only improve our understanding of the 
functions in immune system, but also reveal the design principles behind the details. In 
addition, the study enhances our understanding to the population dynamics in evolution. 
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Introduction 
 
 As one of the adaptive immune responses[1,2,3,4], Affinity Maturation (AM) is 
the procedure in germinal centers (GC) to develop Immunoglobulins (Ig), i.e., antibodies, 
with increased affinities to a new antigen. Understanding the basic functional and 
physical principles of GC kinetics is not only important in medical science, but also 
contributes to the fundamental understanding of molecular evolution[5]. Some 
mathematical models[6,7] made an important effort to describe the B cell population in a 
typical GC as a result of dynamic interactions between mutation and selection. This 
effort, complementary to the studies using Ig sequence data (e.g. [8]), is very important in 
revealing the functions of germinal centers. However, there are still two puzzles in the 
models. First, the experimentally observed somatic hypermutation[9] rate seems so high 
that even B cells expressing antibodies with improved affinities are easily spoiled by the 
majority of deleterious mutations. To resolve the conflict, it is proposed[6,10] that the 
mutation could be switched off periodically. Second, even if the mutation rate is tuned 
periodically, the calculated affinity improvement (up to 15-fold) is still not comparable 
with the observed improvements (~100-fold[11,12,13,14]). Third, a further analysis 
indicated that the models did not reproduce the ‘‘all or none” phenomenon[8]. 
 Since most of the parameters in the models are estimated from experiments with 
considerable uncertainties, it is possible to reconcile the discrepancies by revising the 
parameter values. However, the number of parameters is not small, and it is unclear how 
to find the best parameter values. We notice that the affinity dependent selection results 
from antigen binding kinetics, salvation, and recirculation of B cells. If we replace these 
steps by a phenomenological linear function of affinity to represent the selection, the 
calculations will be significantly simplified, and it will be possible to explore the 
parameter space and look for the optimal design. We hypothesize that AM has been 
optimized in evolution, and expect the B cell population dynamics with these optimized 
parameters to reproduce realistic AM.  
 
Methods 
 
 The model. Each GC is believed to start from a few precursor B cells [15]. These 
precursor B cells first replicate at the perimeter of follicles[16], and the number of B cells 
in a GC reaches thousands when mutations and affinity dependent selections are turned  
on [7,17,18,19,20]. Our model is constructed as follows: 
 First, the model describes the stage with mutation and selection, where the total 
number of germline (initial) B cells in the hundreds of GC in a spleen is ~ . B cells 
replicate at 3~4divisions/day[21,22,23]. To be specific we use 4divisions/day in our 
calculations, corresponding to exponential birth rate r=4ln2=2.8/day. Upon every 
division about one of the two daughter cells are mutated[9], so we find the total mutation 
rate  from
610
mtotal ≈ 2.8 / day exp(−mtotal 0.25) ≈ 1−1 / 2 , although in the calculation below 
we will explore different values of m  to search for the optimal design. It is 
estimated[24,25] that about 50% mutations are silent, 30% are lethal, and the rest 20% 
are the affinity-affecting mutations. The lethal mutation rate  is an effective death 
rate. After taking care of the lethal mutations and neglecting silent mutations, we 
concentrate on the affinity-affecting mutations. The distribution W  of affinity 
total
0.3mtotal
(ΔX)
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change XΔ  upon such mutations (Fig. 1) is estimated from the protein interaction (PINT) 
database[26] (see Supporting Information for details). Note that only 4.9% of affinity-
affecting mutations (equivalent to 1% of all mutations) improve the affinity. 
 Second, selection is considered on the basis of the recent two-photon 
spectroscopic studies which indicate B cells undergo multiple rounds of mutation and 
selection[27] through migration within GC[3,4], consistent with the recycling 
hypothesis[6,7]. B cells compete for antigens and salvation from apoptosis, therefore the 
probability for a B cell to survive in each round depends on the probability to bind an 
antigen in the round, which in turn depends on the affinity of the B cell’s Igs to the 
antigens. According to a standard Langmuir adsorption isotherm the probability to bind 
an antigen in a round of selection is )1/( +⋅⋅ AaAa CKCK  where the association constant 
 (in units of 1/M) describes the affinity and  is the antigen concentration on the 
follicular dendritic cells of GCs. If we describe the affinity by the binding free energy 
, the probability for B cells to survive at each round is 
 for weak affinity, , where
aK AC
)/1ln( aKkTX =
exp[−(X − X0 ) / kT ] X > X0 )ln(0 ACkTX = ; and saturates at 1 
for strong affinity, , reflecting the observation of an affinity threshold[28]. Define X < X0
τ  as the typical time scale for each recycling round. Selection scales the population size 
as exp[−(t / τ )(X − X0 ) / kT ]  after time t for weak affinity B cells, so death/apoptosis rate 
is (X − X0 ) / (kTτ ) . 
 Finally, including the replications, lethal mutations, and selections discussed 
above, the effective growth rate of the B cell population B(X) is 
                         (1) B(X) = r − 0.3mtotal − b(X − X0 )
r − 0.3mtotal
⎧⎨⎩
X > X0
X < X0
(1a)
(1b)
where the selection strength b = 1 / (kTτ )  comes from the above discussion. Defining 
X *  and  as the “neutral” affinity, B*aK (X*) = 0 , we find X* = X0 + (r − 0.3mtotal ) / b  
from Eq. (1a). Population decrease is expected for weak affinity X > X * , and X *  is 
controlled by X  or , which is in turn determined by antigen density, reflecting an 
antigen dosage effect on AM. 
0 AC
 
 Differential equation and analytic solution. Now we are ready to write the 
mean-field differential equation for the population of B cells presenting Ig with affinity X 
at time t: 
       ),('),'()'(),()(),( tXmNdXtXNXXWmtXNXB
dt
tXdN −−+= ∫                      (2) 
where  is rate of the affinity-affecting mutations. (A similar equation was 
considered, in a different context and for fixed population size by Tsimring et. al. [29]) 
As mentioned above, replications, lethal mutations and selections are included in B(X), 
and the affinity-affecting mutations are characterized by 
m ≡ 0.2mtotal
)( XW Δ  in Fig. 1, where 
'XXX −=Δ  is the affinity change.  
 We can solve the mean field equation (2) when Eq. (1) can be simplified as Eq. 
(1a), i.e. the effective growth rate (i.e. replication rate minus death rate) depends linearly 
on the binding free energy in the whole range. Then we rewrite growth rate 
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bXbXB −= 0)(  where 00 3.0 bXmrb total +−≡ . We introduce a Fourier transform of the 
population: 
 N t,ω( )= 1
2π N(X, t)e
−iωX∫ dX                                           (3) 
Then in terms of the Fourier transform population, Eq. (2) looks simple: 
),(]1)(2[),(),(),( 0 tNWm
tNibtNb
t
tN ωωπω
ωωω −+∂
∂−=∂
∂              (4) 
where  
                                                 XdXWeW Xi ΔΔ= ∫ Δ⋅− )(21)( ωπω              
Now denoting 
 Q = ln N ω , t( )                                                      (5) 
we get 
                                       ]1)(2[0 −+=∂
∂+∂
∂ ωπω Wmb
Qib
t
Q                                     (6) 
We seek solution of this equation in the form: 
 )()( ωω SibtRQ +−=                                              (7) 
and get for S: 
                                               )1)((0 −+=∂
∂ ωω Wmb
Sib                                         (8) 
or 
                                         CdW
b
mi
b
mbiS +−−
−= ∫
∞−
ω
ωωπω ')'(20                             (9) 
where C is constant to be determined. 
 
 The function R and the constant C are determined from the initial condition at 
t=0, i.e., the germline distribution of affinities. The general results applicable for different 
initial conditions will be addressed shortly after; for the moment we adopt a most 
common initial condition, Gaussian distribution  
 ⎥⎦
⎤⎢⎣
⎡
Σ
−−Σ== 2
2
2
0
2
)(exp
2
)0,( avXXNtXN π
                                     (10) 
of affinity, or in Fourier space: 
 ⎥⎦
⎤⎢⎣
⎡ −Σ−= avXiNN ωωπω
220
2
1exp
2
)0,(  
Now the function R and constant C can be easily determined from the relation: 
 N ω ,0( )= eQ ω ,0( )  
which immediately gives us )2/ln( 0 πNC =  and final result for R (and Q): 
                            ∫
∞−
+−+−Σ−=
ω
ωωπωωωω ')'(2
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b
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Plugging these results to Eq. (7), we obtain the solution 
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we can define a Fourier transform pair )1()(2),( −Δ
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where ])exp[()0,(),(),(~ 0 tbXbtXNetXgtXN
mt −===  is the population profile in the 
limit of m=0. Due to the linearity of Eq. (2), Eq. (13) applies generally to any initial 
condition.  The total population is 
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The effects of mutations are in the exponent containing m, and this exponent applies 
universally to initial conditions other than Eq. (10). At long enough time beneficial 
mutations  contribute a growing term 0<ΔX ∫∞ Δ ΔΔΔ− 0 )( XdXWXebm
Xbt
 because 
; while the deleterious mutations 1>>Δ− Xbte 0>ΔX   mainly contribute to the population 
reduction term  because .   mt− 1<<Δ− Xbte
 
 Intuitive derivation. An intuitive derivation of (14) helps us understand their 
physical meaning. For convenience we use discrete values of ΔXi = −ih  in Fig. 1, and 
write the total mutation rate as a sum of individual mutation rates, m where  is 
the rate of mutation that change affinity by
= mi
i
∑ mi
ΔXi = −ih . Then Eq. (14) becomes:  
 
N(t) = %N (t) exp
i
∏ [−mit + mibih (ebiht −1)] .                               (15) 
Note that beneficial mutations (i>0) contribute −mit + mibih (e
biht −1) t→∞⎯ →⎯⎯ mi
bih
ebiht  
to . Therefore in the long time limit the beneficial mutations with leads to a super-
exponential population growth 
ln N(t)
N(t) ~ exp[exp(t)] , in comparison to the exponential 
population growth without mutation. If we call the strongest affinity in the population as 
the “nose” affinity, as the “nose” moves toward stronger affinity, the subpopulation at the 
“nose” grows faster, and the speed of “nose” movement becomes faster. 
 The effects of different mutations in Eq. (15) can be factored out, because a) the 
rate  for a mutation of Δmi Xi = −ih  to emerge is independent of the affinity 
distribution N(X, t) , and b) the contribution of a series of mutations {  occurring at 
 to the subpopulation size at a later time t is
ΔXi}
{ti} exp[−bΔXi (t − ti )]
i
∏ , a product of 
individual mutation factors. Therefore, to understand Eq. (14), we can focus on effect of 
only one mutation type with affinity change ΔXi = −ih  and individual mutation rate . mi
 First, in the limit of bÆ0 in Eq. (1), the benefit of mutations is turned off, and the 
average number of mutations B cells experience in the interval t is , and the 
probability to experience j mutations is a standard Poisson distribution 
mit
Pj (t) = exp(−mit) (mit)
j
j!
. It is straight forward to verify 
 
N(t) = %N(t) Pj (t)
j
∑ = %N(t)exp(−mit) 1j!(mit) jj=0
∞∑ = %N(t) .                             (16) 
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Second, for the realistic situation with nonzero b, replication rates of B cells are changed 
by mutations, therefore every  in  is replaced by   mit (mit)
j
mit
mi exp[bih(t − t ')]dt '0
t∫
midt0
t∫ ' =
mi
bih
[exp(biht) −1] ,                                        (17)                
where t’ labels the moment that the mutation occurs. Therefore 
 
N(t) = %N(t) P ' j (t)
j
∑ = %N(t)exp(−mit) 1j![ mibih (ebiht −1)] jj=0
∞∑ = %N(t)exp[ mibih (ebiht −1) − mit]  
(18) 
This matches Eq. (15) and more generally Eq. (14). From Eq. (18), the subpopulation of 
B-cells which undergo j mutations is 
 
N j (t) = %N(t)P ' j (t) = %N(t)exp(−mit) 1j![
mi
bih
(ebiht −1)] j ,                          (19) 
with affinity  stronger than the subpopulation without mutations. If the affinity of the 
initial population are all the same X , then N  is the subpopulation with affinity 
. For i>0, the peak of subpopulation, i.e., largest subpopulation, is at 
jih
in j (t)
Xin + jih
jpeak = mbih (e
biht −1) t→∞⎯ →⎯⎯ m
bih
ebiht ,                                              (20) 
i.e., the peak moves exponentially fast in the long time limit. 
 From Eq. (19) a subpopulation with j mutations grows for two reasons, (a) fed 
from subpopulations with j-1 mutations and (b) self-replication. At short enough time, 
bht<<1, the subpopulation grows dN j (t) / dt ≈ N j−1(t)mi  mainly for the former reason; 
and for large enough time, bht>>1, the subpopulation growth dN  is 
mainly contributed by the latter reason. Therefore, the artifact of self-replication is 
insignificant when time step is much shorter than the characteristic time duration 1/bh. 
j (t) / dt ≈ N j (t) jbh
 
 Numerical calculation for finite population. An artifact in the above derivation 
is that it allows arbitrarily small N(X, t) , and a small subpopulation N(X, t) << 1 within a 
bin of strong affinity X can self-replicate rapidly. However, the B cell numbers in GCs 
are non-negative integers, therefore the expected number of B cells within a bin with 
N(X, t) << 1 should be zero, and cannot become the seed of a rapid growth. So the above 
derivations actually describe the population dynamics in the limit of infinitely large 
population size. It does not take into account the fact[30] that the B cell population size in 
a GC is no more than 10 . 4
 To correct this artifact and calculate the B cell population dynamics numerically 
for various finite initial population sizes including the discreteness effect[7,29], we do not 
allow small subpopulation N(X, t) < 1 in an affinity bin to self-replicate in our numerical 
calculation. Instead, it only represents an accumulative probability for the subpopulation 
in the bin to emerge. Our calculation is done using discrete time steps. From Eq. (15), the 
subpopulation which go through  mutations { ji} ΔX = −ih  between time t and t  is + Δt
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N j1 j2 L ji L(X, t + Δt) = N '(X − ji
i
∑ ih, t)eB( X )te−mΔt [
mi
bih
(ebihΔt −1)] ji
ji !i
∏ ,                 (21) 
where B(X) is given by Eq. (1), and N '(X, t)  is the population distribution excluding the 
bins with less than one B cells. The population distribution after a time step is  
 
N(X, t + Δt) = N(X, t) − N '(X, t) + L LN j1 j2 L ji L(X, t + Δt)
ji =0,1,L
∑
j2 =0,1,L
∑
j1 =0,1,L
∑   (22) 
The time step  is set to 0.01/bh, much smaller the characteristic time duration 1/bh，
such that the growth of subpopulations with relatively strong affinities is dominated by 
mutation influx rather than self replication. We include multiple mutations in one time 
step. This calculation is rapid to perform even for large population sizes, and allows us to 
explore the parameter space.  
Δt
 
Results and Discussion 
 
 We calculate the total population size of B cells N(t)  for various initial 
population sizes numerically (dotted lines in Fig. 2). The total number of B cells first 
decreases because the initial affinity is weaker than the neutral affinity . The average 
affinity is improved continuously (see Fig. S2 in Supporting Information) rather than 
abruptly, in agreement with experiments[27]. Once the average affinity reaches  the 
population begins to increase. The picture of decrease and increase of the B cell 
population was observed experimentally[31] and theoretically[7], although the 
experimental data on GC temporal development[31] is too limited to verify the model. 
The lowest total population corresponds to the neutral affinity ; and we call it the 
population bottleneck, because it is the most challenging moment for the population to 
survive. The analytical result Eq. (14) (solid line) can describe the population size at the 
decreasing stage. A smaller initial population leads to a slower growth after the 
bottleneck (yellow). For a small enough initial population (red), the B cell population is 
extinct when approaching the bottleneck, and cannot recover thereafter. Therefore, the 
initial population size should be large enough to ensure some B cells can survive through 
the population bottleneck. Similarly, for a given initial population size, a weaker initial 
binding leads to a deeper bottleneck, and takes a longer time to recover. If the initial 
binding is too weak, the bottleneck will be too deep, and the population will go extinct.  
*aK
*aK
*aK
 The initial population is set to 10  B cells in realistic calculations to include the 
existence of hundreds of GCs in a spleen[32] and the peak number of thousands of B 
cells per GC [33]. Different GCs in a spleen might not be perfectly synchronized[34]. If 
the B cell production rate in a spleen is limited by supply of resources, we conjecture the 
time that GCs start mutation and selection might vary between day 3 and day 8 or later, 
so that the population peaks of GCs is smeared. This agrees with the observation [35] that 
the total population at any moment does not exceed 
6
2.5 ×105  B cells. The population 
bottleneck within a GC might also be smeared by the continued immigration of B cells 
from nonfollicular sites[19,36], making the bottleneck less pronounced or harder to 
observe directly. If all the B cells in a GC die away, the antigens are not exhausted, and it 
is proposed that more B cells immigrate to the GC[34], probably from GCs which have 
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passed the bottleneck and have many B cells, although the current experiments cannot 
determine whether there is migration between GCs[34]. The calculations below are first 
performed with 10  initial B cells, which is valid in the limit of fast migration between 
GCs in a spleen. In this case, the few GCs which by chance pass the bottleneck earlier 
than others may make significant contributions to the affinity improvement of the whole 
spleen. Then we study the case in the opposite limit, i.e. the affinity improvement of a 
typical GC with 3000 initial B cells, assuming no B cell migration between GCs. By 
comparing these two cases we will quantify the contribution of migration to affinity 
improvement. 
6
 We explore the parameter space to look for the optimum design of GCs that 
maximizes the affinity improvement (Fig. 3) in the limit of fast B cell migration between 
GCs (  initial B cells). AM terminates probably due to exhaustion of available 
antigens[37,38] or emigration of B cells[37,39]; and the termination could be described to 
occur after a certain time scale, or when the B cell population size is big enough--
probably comparable to its original size,. So we assume (in Fig. 3a) termination of AM in 
14 days or when the B cell population size recovers the initial value after going through 
the bottleneck. The affinity improvement is indicated by the total affinity A, i.e., the sum 
of Ka for all B cells, such that the situation with very few cells at day 14 should not be 
regarded as efficient improvement. The improvement of affinity in Fig. 3a is calculated 
for various initial binding levels and mutation rates. The highest affinity improvement is 
450-fold. This optimal improvement occurs at mutation rate m  
(corresponding to the observed fraction of 50% daughter cells mutated), for the binding 
level between germline (initial) antibodies and antigens X
106
total ≈ 2.8 / day
in = X *+1kcal / mol  or 
18.0)//1exp(*/)0( =−= kTmolkcalKK aa , and selection strength 
 (see Fig. S3 and S4 in Supporting Information). This result 
agrees with several experimental observations. First, the affinity improvement agrees 
with the observation of ~100-fold[11,12,13,14] improvement. Second, the theoretically 
optimal value to provide maximal affinity improvement agrees with the observed in vivo 
somatic hypermutation rate[9]. Third, the improvement of affinity corresponds to 
ln(450)kT=3.6kcal/mol of free energy improvement. Combining with the typical affinity 
improvement 
b = 0.7 / day(kcal / mol)
Y ≈ 0.4kcal/mol of an affinity improving mutation, we can estimate that a 
final B cell contains 3.6/0.4=9 mutations in their V regions of Ig genes, in agreement 
with the observed ~9 mutations per Ig gene[9,40,41,42,43]. From the definition 
b = 1 / (kTτ ) , the optimal selection strength b=0.7/day/(kcal/mol) corresponds to an 
optimal time of a recycling round τ = 1 / (kTb) ≈ 2.4 day, compatible with the earlier 
model[7].  
 Fig. 3b helps to reveal the design principles of GCs, where the affinity 
improvement is calculated when the B cell population size recovers the initial value after 
going through the bottleneck, no matter how long it takes. In general, the affinity 
improvement is not effective for too strong initial bindings, which results in shallow or 
no bottlenecks and rapid population recoveries, hastily terminating the AM before 
accumulating adequate improvements. As the initial binding becomes weaker, the 
population bottleneck is deeper, and the affinity improvement is more effective, but takes 
a longer time. The improvement shown in Fig. 3b could even exceed 1000-fold for a 
weak initial binding X , although such improvements take much in = X *+1.5kcal / mol
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longer than 14 days and would be interrupted in the calculation with fixed AM time as 
shown in Fig. 3a. If the initial binding becomes even weaker, the population bottleneck is 
so deep that the whole population goes extinct and no longer recovers (grey scales in Fig. 
3b obtained numerically). Therefore, for a given mutation rate, the most effective affinity 
improvement occurs when initial binding level is near the critical value (red in Fig. 3b), 
where the population can barely survive through the population bottleneck, i.e. only a few 
GCs can survive. A somewhat stronger initial binding improves affinities less effectively, 
but it takes a shorter time for the AM to finish, and faster AM is advantageous. Taking all 
these into consideration, in the optimal design of GCs, the most commonly appeared 
initial bindings should be adjusted to be somewhat stronger than the critical value, so that 
affinities are improved effectively, timely, and safely. This picture agrees with the 
observed dependence of B cell fate on initial antibody-antigen binding level or antigen 
density[44] [45], where too strong initial bindings (beyond Ka* in our model) do not lead 
to GC formation, moderate initial bindings (e.g. molkcalXXin /5.0*+=  in our model) 
result in GC response which finishes quickly, while weaker initial affinities (e.g. 
 in our model) result in tempered GCs. To achieve the optimal 
design, the 
Xin = X *+1kcal / mol
Ka*  values might have been adjusted in evolution by tuning the antigen 
density or modulating the diversity of the germline pool achieved through somatic 
recombination. When mutation rate is so high that 80% or more daughter cells are 
mutated, the lethal mutations preclude sustainable replications of B cells, i.e., the 
population growth rate in Eq. (1) becomes negative for any affinity. This lethal 
mutagenesis region is shown in black in Fig. 3b.  
 Exploration of the parameter space helps us sketch some general design principles 
of the GCs. First, for the affinity to be improved most effectively, the B cell number 
should first decrease to reach a population bottleneck and then increase. A weaker initial 
binding results in a higher affinity improvement, unless the population recovery after the 
bottleneck becomes too slow, or even takes forever in the extinct case. Second, the 
seemingly high mutation rate is actually set to optimize the success rate of AM. On one 
hand, the optimal mutation rate, in agreement with somatic hypermutation in vivo, is 
quite high because the improvement of affinity comes only from mutations. On the other 
hand, if the mutation rate gets higher, the large number of lethal mutations will spoil the 
cell replications. Third, we expect that the selection strength b is the optimal value 
b=0.7/day/(kcal/mol), which sets an important guide to future simulations of GCs. 
Indeed, a large enough b ensures adequate preference for stronger affinity B cells in 
selection; but if b is too large, the initial weak binding B cells vanish quickly before 
enough beneficial mutations can accumulate.  
 B cell migration between GCs could be beneficial to the AM, as indicated by the 
calculated affinity improvement of a typical GC with 3000 initial B cells in the limit of 
no migration (Fig. 4). A stronger initial binding molkcalXXin /5.0*+=  is needed to 
ensure a typical GC to survive through the bottleneck; and the optimal affinity 
improvement becomes 70-fold for the GC, still consistent with the experimental value (of 
the order ~100-fold[11,12,13,14]). This is achieved in 16 days, only slightly longer than 
two weeks, therefore separate diagrams like in Fig. 3a and b is not necessary. The 
maximal improvement in this case is ~6-7 times lower than the result in the limit of fast 
migration, where a factor of ~3 comes from the change in initial binding level, and a 
factor of ~2 comes from the difference between the average of all GCs and the “typical” 
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or median individual GC. In other words, fast B cell migration between GCs could 
enhance the affinity improvement by a factor of about 6-7 in our model.  
 Our model is consistent with the ‘‘all or none[8]” phenomenon observed in 
experiments[19,46,47], i.e., the fraction of strong affinity cells in a GC is most likely 
either very high or very low, where the strong affinity B cells are characterized by a 
certain key mutation[46,47] or a unique piece of Ig gene sequence[19]. Presumably the 
GCs dominated by strong affinity mutants have gone through the population bottleneck, 
and this phenomenon is the most pronounced in the case without B cell migration 
between GCs. Indeed, it is possible for different individual GCs to fall into two categories 
according to whether they have passed the population bottleneck, and the choice of 
category for a GC depends on both the initial binding level and stochastic effect. 
Moreover, if many GCs in a spleen start from the same initial condition but each has a 
random starting time, then the fractions of strong affinity B cells in the GCs at a given 
moment is expected to be distributed as in Fig. 5, where affinities beyond Ka* are 
defined as strong. Fig. 5 is obtained as follows. During the development of a typical GC 
(Fig. 2 and S2), we can track the fraction F(t) of strong affinity B cells in the GC all the 
time. Observing the whole ensemble of GCs at a given moment is equivalent to observing 
a single GC at many arbitrary moments. Therefore, we transform F(t) into t(F), and the 
distribution is P(F)~dt(F)/dF up to a normalization factor. As we see in Fig. 5, the 
probabilities to observe high or low fraction values are significantly larger than that of 
intermediate fraction values. Therefore, our model is consistent with the ‘‘all or none” 
phenomenon. If B cell diffusions between GCs exist, this phenomenon is somewhat 
smeared.  
 We obtain mutation effects W (ΔX)  from the PINT database which presents the 
data on interactions between all kinds of proteins[26] because we do not have adequate 
real data of affinity change upon mutations of Ig. The existing analysis of Ig sequence 
data in the immune response of PhOx and NP[8] is consistent with the distribution we 
obtain from PINT database. Indeed, 3.2% (for PhOx) or 1.0% (for NP) of the affinity 
affecting mutations could improve affinity strongly (10-fold), while in our model 4.9% 
improves affinity and 1.4% improves affinity strongly (5-fold). Our assumption that the 
distribution of affinity change W (ΔX)  is independent on the affinity might not hold for 
all affinities, although our model only requires this assumption to be valid just for a range 
2-4 kcal/mol of affinities.  
 What are the major differences between our model and the earlier theoretical 
models? First, the affinity improvement we achieve is higher than the earlier theoretical 
models, which resolves the discrepancy between theory and experiment. If we examine 
Oprea-Perelson model[7] in our framework, the reason that the earlier model did not 
achieve higher improvements might be that it used a smaller selection strength b than the 
optimal value. Indeed, the choice to enter a recycle in the Oprea-Perelson model is 
stochastic, so the chance for weak affinity B cells to survive is enhanced by choosing not 
to enter a cycle and therefore avoiding selection. A larger selection strength b brings a 
high risk of AM failure, but provides a higher affinity improvement, and this can be 
achieved if all B cells experience similar number of recycles rounds. The low optimal 
value of mutation rate in the earlier model might result from the small selection strength. 
Second, the major simplification we make is to use Eq. (1) to replace the binding kinetics 
between Ig and antigens, salvation, recycling, the distinction between different B cell 
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phenotypes such as centroblasts and centrocytes, and the separation of dark and light 
zones, which were considered in details in earlier theoretical studies[7,8,37,38,39,48,49]. 
We assume that competition for antigen and T-cell help effectively results in the 
dependence of death rate of B cells on their affinity to an antigen, and we provided an 
argument that such dependence should be linear in binding free energy of Ig-antigen 
interaction. We expect that this simplification captures the key factor determining the 
AM. Such a coarse-grained description reduces the parameter space greatly, making it 
possible to search the whole parameter space for optimal design of GC. With this basic 
picture, we can build more detailed simulations to reproduce the complete procedures of 
AM.  
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Figure Captions 
 
 
Figure 1: Histogram of affinity improvement upon single mutations from the PINT 
database. The silent or lethal mutation is not included in the figure. Here the bin size is 
h=0.5 kcal/mol (equivalent to 2.3-fold in Ka), and the unit of W is ( . Only 
4.9% of the affinity affecting mutations could improve affinity. 
kcal / mol)−1
 
Figure 2: Total population as a function of time for various initial population sizes, 
starting from germline (initial) Ig-antigen binding level Xin = X *+1kcal / mol  or 
, with b  and18.0*/ =KaKain = 0.7 / day(kcal / mol) mtotal = 2.8 / day . Solid line: exact 
analytical result for infinite population size, Eq. (14). Dotted lines: numerical results for 
initial population sizes N  (green), 10 (yellow), and 10  (red) respectively.  The 
population in red goes extinct at the bottleneck. 
0 = 107 5 2
 
Figure 3: The improvement of affinity for the whole spleen including many GCs in the 
limit of rapid B cell migration between GCs. The improvement of affinity (in Ka) is 
shown in color code, as a function of mutation rate and initial binding level, assuming 
AM is terminated (a) either after 14 days or when the population recovers the initial size 
(1 B cells) after going through the bottleneck, or (b) when the population recovers the 
initial size after going through the bottleneck, no matter how long it takes. (a): The 
optimal improvement of A (sum of Ka over all B cells) occurs when about 50% daughter 
cells are mutated at divisions. (b): The grey scale shows the probability for the whole 
population to survive through the bottleneck. The black region at high mutation rate 
indicates lethal mutagenesis where there are too many lethal mutations for B cell 
population to increase.  
06
 
Figure 4: The improvement of affinity for an isolated GC, i.e., in the limit of no B cell 
migration between GCs. The improvement of affinity (in Ka) is shown in the same color 
code as in Fig. 3a, assuming AM is terminated when the population recovers the initial 
size (3000 B cells). The optimal improvement of affinity occurs when about 60% 
daughter cells are mutated at divisions, and takes 16 days. The grey scale shows the 
probability for a GC to survive through the bottleneck. 
 
Figure 5: The distribution of F, fraction of strong affinity B cells, for many GCs which 
follow similar development patterns but each starts from a random time, is consistent 
with the “all or none” phenomenon. Every GC has initial binding level 
, 50% mutated daughter cells, and selection strength 
. The calculation is terminated as F reaches 85%, when the 
number of B cells in the GC recovers the initial value (3000). 
molkcalXXin /5.0*+=
b = 0.7 / day(kcal / mol)
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Supplementary Information 
 
Affinity change upon mutations: From the PINT (protein interaction) database[1], the 
change of affinity upon mutations does not have obvious correlation with the affinity 
before mutations (Fig. S1). The fraction of beneficial mutations has no significant 
dependence on the affinity, especially for the typical range of affinity maturation 
 or 1916 1010 −− << MKaM molkcalXmolkcal /8/12 −<<− . The detrimental mutations 
in Fig. 1 can be fitted by )]/87.1/(exp[48.0)( molkcalXXW Δ−=Δ , while the data of 
beneficial mutations can be fitted by )]/43.0/(exp[18.0)( molkcalXXW Δ−=Δ .  
 
 
 
Fig. S1: The scatter plot of affinity X and the change of affinity XΔ  from PINT 
database, which does not show significant correlation. 
 
Survival probability: If the initial B cell population is too small, the population might 
not pass through the bottleneck, but rather becomes extinct. To calculate the survival 
probability of the whole population numerically, we start from an initial B cell with weak 
affinity X, corresponding to a death rate B(X)  larger than the replication rate 
. The initial cell and its descendants could either die or replication and/or 
mutate with some well defined probabilities. By collecting the probability distribution of 
each cell’s fate, we numerically calculate the probability for some descendants to reach a 
strong affinity 
totalmr 3.0−
hX 10*− . In this way we find the probability p for some descendants of 
the initial B cell with affinity X to eventually survive, and use p to find the expected 
probability for the system of  initial B cells to survive rather than become extinct. 610
 
Gradual improvement of affinity: We can monitor the distribution of affinity at 
different moments (Fig. S2). The population starts from identical weak affinity B cells 
 or Xin = X *+1kcal / mol 18.0*/ =KaKain , and has an initial population decrease; but B 
cells with stronger affinities gradually emerge, and become dominant due to selection, 
and the population size grows thereafter. The continuous improvement of affinity is 
supported by experiments[2].  
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Figure S2: Affinity distribution in the population N(X, t)  at t=3 (solid), 6 (dashed), 9 
(dotted), and 12 (dash-dotted) days, starting from germline affinity 
 or Xin = X *+1kcal / mol 18.0*/ =KaKain , with initial population N , selection 
strength  and effective mutation rate . The 
average affinity improves with time; while population size shrinks then grows. 
0 = 106
b = 0.7 / day(kcal / mol) mtotal = 2.8 / day
 
Affinity Improvement as a function of selection strength: We look for the optimal 
values of mutation rate m, selection strength b and initial binding level  that 
maximize affinity improvement for the case of fast B cell migration between GCs (i.e. 
 initial B cells). The variables in Fig. 3a are m and 
*XX in −
N0 = 106 *XX in − , and here we plot 
the improvement of affinity in the plane of b and m (Fig. S3), and in the plane of b and 
 (Fig. S4). At each given value of b and m in Fig. S3, different initial affinities 
, 0.5, 1, 1.5, and 2kcal/mol are calculated, and the initial affinity resulting in 
the strongest affinity improvement is chosen. To maximize the affinity improvement, the 
optimal mutation rate is at 50% daughter cells mutated at each replication, and the 
optimal selection strength is b=0.7/day/(kcal/mol).  
*XX in −
0*=− XXin
 
 
 
Fig. S3: Optimization of b and m. The color indicates the improvement of total affinity. 
Here different initial affinities are tried for each mutation rate and b, and the one which 
gives largest affinity improvement is chosen. b=1.2/day/(kcal/mol) is the global optimal 
selection strength. A minor local peak at b=1.2/day/(kcal/mol) might be an artifact due to 
discrete (rather than continuous) choices of initial affinity values.  
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Fig. S4: The improvement of total affinity as a function of selection strength and initial 
affinity. Here mutation rate is chosen as the optimum value, i.e. m=0.55/day/gene or 50% 
mutated daughter cells. 
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